Investors: Press Releases

Press Releases

May 27, 2021
NexImmune Announces Formation of Scientific Advisory Board
May 19, 2021
NexImmune Announces Presentation of Preliminary Phase 1/2 Clinical Data at the 2021 American Society of Clinical Oncology Annual Meeting
May 17, 2021
NexImmune Reports First Quarter 2021 Financial Results and Recent Updates
April 21, 2021
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
March 31, 2021
NexImmune Reports Fiscal Year 2020 Financial Results and Recent Updates
March 2, 2021
NexImmune to Present at the 2021 Barclays Global Healthcare Conference
February 17, 2021
NexImmune Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 11, 2021
NexImmune Announces Pricing of Upsized Initial Public Offering
January 19, 2021
NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member
January 18, 2021
Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Officer
Displaying 31 - 40 of 60